CHAPEL HILL, N.C.--(BUSINESS WIRE)--Robert L. Ferris, MD, PhD, a head and neck surgical oncologist, leading expert in cancer immunotherapy and cancer center chief executive, has been named the executive director of UNC Lineberger Comprehensive Cancer Center, and UNC system chief of oncology services, effective October 1st, announced UNC School of Medicine Dean Wesley Burks, MD..

北卡罗来纳州教堂山——（商业新闻短讯）——美国北卡罗来纳大学医学院院长卫斯理·伯克斯（WesleyBurks）宣布，头颈外科肿瘤学家、癌症免疫治疗首席专家和癌症中心首席执行官罗伯特·费里斯（RobertL.Ferris）医学博士被任命为北卡罗来纳大学莱因伯格综合癌症中心（UNCLineberger Comprehensive cancer center）执行主任，北卡罗来纳大学系统肿瘤服务负责人，自10月1日起生效。。

Ferris comes to UNC from the University of Pittsburgh Medical Center (UPMC), where he was the director of the Hillman Cancer Center. He succeeds Shelley Earp, MD, who served as UNC Lineberger director twice, 1997-2014 and 2018-2024. Earp announced his intent to stepdown as director last fall. He will continue as a faculty member of UNC School of Medicine and the cancer center, to lead his lab at UNC Lineberger, and service to external organizations, including as chair of the National Cancer Institute’s Board of Scientific Advisors..

费里斯是匹兹堡大学医学中心（UPMC）的主任，也是希尔曼癌症中心的主任。他接替了医学博士雪莱·厄普（ShelleyEarp），后者曾在1997-2014年和2018-2024年两次担任UNC Lineberger董事。厄普去年秋天宣布打算辞去导演一职。他将继续担任UNC医学院和癌症中心的教员，领导他在UNC Lineberger的实验室，并为外部组织服务，包括担任国家癌症研究所科学顾问委员会主席。。

“Bob Ferris is an exceptional cancer physician-scientist, a highly skilled health executive with deep experience leading a NCI comprehensive cancer center, and a person with a genuine passion for service to others,” said Burks, vice chancellor for medical affairs at UNC School of Medicine and CEO of UNC Health.

UNC医学院医学事务副校长兼UNC health首席执行官伯克斯（Burks）表示：“鲍勃·费里斯（BobFerris）是一位杰出的癌症医生科学家，是一位拥有领导NCI综合癌症中心丰富经验的高技能健康管理人员，也是一位真正热爱为他人服务的人。”。

“This blend of skills, experience and vision makes Bob the ideal person to lead our cancer center and to expand on the leadership successes of Joe Pagano, Ned Sharpless and Shelley Earp, under whose direction UNC Lineberger has become one of our country’s great cancer centers.”.

“这种技能、经验和远见的结合，使鲍勃成为领导我们癌症中心的理想人选，并扩大了乔·帕加诺（Joe Pagano）、内德·夏普利斯（Ned Sharpless）和雪莱·厄普（Shelley Earp）的领导成就，在他们的指导下，联合国大学莱因伯格（UNC Lineberger）已成为我国伟大的癌症中心之一。”。

The appointment marks a return to Chapel Hill for Ferris, who earned his bachelor’s degree in chemistry with honors and distinction from UNC-Chapel Hill. He earned his medical degree and his PhD in immunology from Johns Hopkins Medical School, where he also completed his residency, and was chief resident, in otolaryngology / head and neck surgery..

这一任命标志着费里斯重返教堂山，他以优异的成绩获得了北卡罗来纳大学教堂山分校的化学学士学位。他在约翰·霍普金斯医学院获得了医学学位和免疫学博士学位，并在那里完成了住院医师资格，并且是耳鼻咽喉/头颈外科的首席住院医师。。

Ferris has served as director and associate senior vice chancellor for cancer research at UPMC Hillman Cancer Center since 2017, and senior vice president for oncology programs at UPMC and associate senior vice chancellor for cancer research at the University of Pittsburgh starting in 2023. Under his leadership, UMPC Hillman’s clinical, academic and research faculty and activities were more closely aligned.

自2017年以来，费里斯一直担任UPMC希尔曼癌症中心癌症研究主任兼副高级副校长，2023年起担任UPMC肿瘤项目高级副总裁和匹兹堡大学癌症研究副高级副校长。在他的领导下，UMPC Hillman的临床，学术和研究师资和活动更加紧密。

This, among other things, generated a 29% increase in peer-reviewed cancer research funding ($106 million, up from $82 million) and a 53% increase in National Cancer Institute funding ($48 million, up from $31.2 million). The center also obtained or renewed three highly sought after NCI Specialized Programs of Research Excellence (SPORE) research grants (in head neck, skin and ovarian cancers) and multiple principal investigator grants..

除其他外，同行评审的癌症研究资金增加了29%（从8200万美元增加到1.06亿美元），国家癌症研究所资金增加了53%（从3120万美元增加到4800万美元）。该中心还获得或更新了三项备受追捧的NCI卓越研究专业计划（SPORE）研究资助（头颈癌，皮肤癌和卵巢癌）和多项首席研究员资助。。

Ferris has led a highly productive clinical, translational and laboratory research enterprise during his tenure at Hillman Cancer Center, which has led to the founding of two companies and the publication of more than 450 peer-reviewed scientific papers and book chapters.

费里斯（Ferris）在希尔曼癌症中心（Hillman Cancer Center）任职期间，领导了一家高效的临床，转化和实验室研究企业，成立了两家公司，发表了450多篇同行评审的科学论文和书籍章节。

He has been the principal investigator of multiple cancer immunotherapeutic trials, including several studies investigating treatment deintensification for HPV+ head and neck cancer after transoral surgery. He is the principal investigator of the Specialized Programs of Research Excellence in head and neck cancer.

他一直是多项癌症免疫治疗试验的主要研究者，包括几项研究经口手术后HPV+头颈癌治疗去强化的研究。他是头颈癌卓越研究专业项目的首席研究员。

His translational research has generated fundamental insights into the mechanisms of anti-tumor immunity in the tumor microenvironment and tumor cell escape. His lab pioneered studies demonstrating innate and adaptive immune responses induced by cetuximab, the EGFR-specific monoclonal antibody, in head and neck cancer.

他的转化研究为肿瘤微环境中的抗肿瘤免疫机制和肿瘤细胞逃逸提供了基本见解。他的实验室率先开展了研究，证明了EGFR特异性单克隆抗体西妥昔单抗在头颈癌中诱导的先天性和适应性免疫反应。

The team is also investigating immunosuppressive molecules, including immune checkpoint receptors PD-1, CTLA-4, TIM-3, and LAG-3..

该团队还在研究免疫抑制分子，包括免疫检查点受体PD-1，CTLA-4，TIM-3和LAG-3。。

Ferris also had a longstanding commitment to external service. He co-chaired the NCI Steering Committee for Head and Neck Cancer and is the immediate past president of the American Head and Neck Society. He serves on the external advisory boards for MD Anderson Cancer Center, University of Pennsylvania Abramson Cancer Center and the Georgetown Lombardi Cancer Center.

费里斯还长期致力于对外服务。他是NCI头颈部癌症指导委员会的联合主席，也是美国头颈部协会的前任主席。他是MD安德森癌症中心、宾夕法尼亚大学艾布拉姆森癌症中心和乔治敦伦巴第癌症中心的外部咨询委员会成员。

He also is editor-in-chief of Oral Oncology and on the editorial board for Clinical Cancer Research and Cancer Immunology Research..

他还是《口腔肿瘤学》的主编以及《临床癌症研究》和《癌症免疫学研究》的编辑委员会成员。。

About UNC Lineberger

关于UNC Lineberger

The UNC Lineberger Comprehensive Cancer Center is a cancer research and treatment center at the University of North Carolina at Chapel Hill. Serving patients at the N.C. Basnight Cancer Hospital, UNC Lineberger is the only public comprehensive cancer center in the state of North Carolina.

北卡罗莱纳大学莱恩伯格综合癌症中心是北卡罗莱纳大学教堂山分校的一个癌症研究和治疗中心。。

As one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers, UNC Lineberger was rated as exceptional – the highest category – by the National Cancer Institute. The center brings together some of the most exceptional physicians and scientists in the country to investigate and improve the prevention, early detection and treatment of cancer..

作为仅有的57个国家癌症研究所指定的综合癌症中心之一，UNC Lineberger被国家癌症研究所评为“杰出”类别（最高类别）。该中心汇集了国内一些最杰出的医生和科学家，以调查和改进癌症的预防，早期发现和治疗。。

With research that spans the spectrum from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials..

通过从实验室到床边再到社区的研究，UNC Lineberger教师致力于从遗传和环境层面了解癌症的原因，进行开创性的实验室研究，并将研究结果转化为开创性和创新性的临床试验。。